New to endotoxin texting?
If endotoxin testing is new to your organisation, the first challenge is rarely the assay itself — it is knowing where to start. CMD helps you define what is actually needed and choose the right route forward.
Starting endotoxin testing?
What this typically looks like in practice
For many teams, endotoxin testing does not begin as a planned capability. It becomes necessary at a specific point: when a product moves closer to clinical use, when a customer or partner introduces new requirements, or when existing microbiological controls are no longer sufficient on their own.
At this stage, the challenge is rarely technical in isolation. It is about understanding what is expected, how it applies to your product or process, and how to implement a testing approach that is both compliant and proportionate.
In practice, this often means working with incomplete information, balancing time pressure with regulatory expectations, and deciding whether to build internal capability or rely on external expertise.
Why this stage often feels more complicated than it should
-
For most organisations, it becomes a live issue when something changes: a product moves closer to clinical or commercial use, a customer introduces a requirement, or a quality team needs greater clarity around release and control. Teams are then expected to move quickly while still making sound decisions on scope, testing model and documentation.
-
"Sterile", "low bioburden" and "pyrogen-free" are not interchangeable with endotoxin control. A product can have low viable contamination and still present an endotoxin risk. These distinctions matter early (not only at inspection or during troubleshooting) and are worth resolving before a testing strategy is set.
-
New adopters rarely need a supplier that simply processes a sample and returns a result. They need help interpreting the context: what the sample is, what route makes sense, what information should be prepared, and whether outsourced testing or in-house capability is the better operational fit.
How CMD helps first-time users move forward
We help you define what is actually needed
The first step is not to fit every organisation into the same workflow. It is to understand your product, matrix, application and stage of development, then identify the most sensible testing route, including whether endotoxin testing is relevant at all, and what sample details will be required.
We remove unnecessary complexity
For organisations new to this area, complexity often comes from fragmented advice and poorly matched solutions. If outsourcing is the right choice, CMD provides a structured service model. If your volume and operational model point towards in-house implementation, αBET® offers a compliant system designed to simplify execution from day one.
We support the next step
Some clients come with one immediate requirement. Others are building a longer-term quality strategy. In both cases, the value lies in choosing an approach that works now without becoming a constraint later.
Application areas we support
Purified water and water for injection
When testing frequency is high, workflow efficiency matters as much as analytical performance. CMD supports laboratories seeking either a more practical in-house routine testing model or a trusted outsourced partner for defined water monitoring programmes.
Haemodialysis water and dialysis fluids
Haemodialysis requires disciplined endotoxin control. CMD supports this application with testing approaches suited to routine monitoring and compliance-led workflows, where endotoxin limits and action levels are clearly defined.
Injectables and conventional pharma
Endotoxin testing is established practice here. The opportunity is not to reinvent the assay. It is to remove unnecessary cost, waiting time and operational friction from a process that has to work consistently, every time.
Critical water for medical device processing
As expectations around critical water quality become more explicit, organisations need testing strategies that align with current standards and support defensible control. CMD can support both the practical testing requirement and the wider discussion around implementation.
Choose the support model that fits your opperation
Discover how our αBET technology or expert testing service can solve your specific needs
Bring routine testing in-house with αBET®
Best suited to teams that run frequent water or product tests, need faster turnaround for operational decisions, want lower recurring test costs, or want to reduce dependence on external testing for day-to-day work.
Outsource to CMD testing services
Best suited to teams that need accredited or external results, test less frequently, require method development or validation support, need overflow capacity, or want specialist support without implementing a new platform.
Regulatory Context
Healthcare water and conventional pharmaceutical testing sit within a clearly defined regulatory landscape, even when the matrices are familiar. Endotoxin limits and action levels for haemodialysis applications are well established. ANSI/AAMI ST108 has sharpened expectations around water quality and control in medical device processing. And in conventional pharmaceutical manufacturing, routine endotoxin testing remains part of the obligation to generate pharmacopoeia-aligned, defensible data.
CMD's role is to help clients operationalise those requirements in a way that is technically sound and commercially realistic, not to add a further layer of complexity to work that is already well understood.
Latest News and Resources
Talk to CMD about your workflow
If your work involves purified water, WFI, haemodialysis fluids or conventional pharmaceutical products, we can help you assess the right testing model for your operation.
The conversation usually starts with a straightforward question about your current set-up.